FDA Approves Eli Lilly’s GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Discover the latest breakthroughs in technology, from innovative startups to major industry shifts. CurioAtlas curates articles on gadgets, software, hardware, and digital culture to keep you ahead of the curve.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
Article URL: Comments URL: Points: 14 # Comments: 2
Last month, Swiss Finance Minister Karin Keller-Sutter filed a criminal complaint over an offensive Grok post generated by an X user that requested that the chatbot “roast” the government official. According to Bloomberg, Keller-Sutter’s complaint seeks to hold the X…
Elon Musk’s rocket company SpaceX has confidentially filed to go public, firing the starting gun on what is expected to be the biggest initial public offering in history. The Texas-headquartered company had this week filed paperwork with the Securities and…
Meta’s upcoming Hyperion AI data center will be powered by 10 new natural gas plants.
A new study from researchers at UC Berkeley and UC Santa Cruz suggests models will disobey human commands to protect their own kind.
The HP OmniBook 5 is a better laptop than the MacBook Neo in almost every way. Right now, it’s also $100 cheaper.
Article URL: Comments URL: Points: 16 # Comments: 7
Star Wars producer Kathleen Kennedy was one of the few skeptics at the Runway AI Summit, where AI was compared to fire and the printing press just a week after Sora’s death.
Article URL: Comments URL: Points: 7 # Comments: 0